|
RARS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.081600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.819200E-03 |
| Normal-vs-Stage2 |
2.053600E-02 |
| Normal-vs-Stage3 |
1.009670E-02 |
| Normal-vs-Stage4 |
3.201600E-02 |
| Stage1-vs-Stage2 |
9.534000E-01 |
| Stage1-vs-Stage3 |
9.359200E-01 |
| Stage1-vs-Stage4 |
9.940400E-01 |
| Stage2-vs-Stage3 |
9.179400E-01 |
| Stage2-vs-Stage4 |
9.628400E-01 |
| Stage3-vs-Stage4 |
9.644800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.658700E-03 |
| Normal-vs-AfricanAmerican |
1.038820E-01 |
| Normal-vs-Asian |
1.452260E-02 |
| Caucasian-vs-AfricanAmerican |
8.438800E-01 |
| Caucasian-vs-Asian |
7.935400E-01 |
| AfricanAmerican-vs-Asian |
6.927400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.736100E-03 |
| Normal-vs-Female |
4.896400E-03 |
| Male-vs-Female |
5.560000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.742200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.540900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.672460E-02 |
| Normal-vs-Age(81-100Yrs) |
5.049400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.763200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.429400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.504600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.219000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.377000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.999800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.965200E-01 |
| Classical-VS-Follicular |
2.68699999994571E-06 |
| Classical-VS-Other |
6.848100E-02 |
| Classical-VS-Normal |
6.508200E-02 |
| Tall-VS-Follicular |
1.622120E-02 |
| Tall-VS-Other |
1.661360E-01 |
| Tall-VS-Normal |
1.199610E-01 |
| Follicular-VS-Other |
9.641800E-01 |
| Follicular-VS-Normal |
2.02989999997794E-06 |
| Other-VS-Normal |
1.734320E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.461640E-03 |
| Normal-vs-N1 |
2.680200E-03 |
| N0-vs-N1 |
4.269000E-01 |
|
|
